Statistics for spatial transcriptomics outcome for Visium_FFPE_Mouse_Pancreas in ID β Hltf-KO (Sample ID, A and B) and IC β Hltf-KO (Sample ID, C and D).
A 63-year-old male who received ciltacabtagene autoleucel (cilta-cel) CAR-T cells and the GPRC5DxCD3 bispecific talquetamab for early relapse of his multiple myeloma (MM) developed a leukemic peripher
